Fundamental Valuation Report Livent(LTHM:NYS) Basic Materials:Specialty Chemicals This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$17.06 (USD) 03/26/2021 Weighted Valuation$16.47 (USD) Overall RatingFairly valued to slightly Overvalued by 3.5% Valuation Models …
Livent (LTHM:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Main Street Capital(MAIN:NYS) Financial Services:Asset Management This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$39.26 (USD) 03/26/2021 Weighted Valuation$38.11 (USD) Overall RatingFairly valued to slightly Overvalued by 2.9% …
Main Street Capital (MAIN:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Allscripts Healthcare(MDRX:NAS) Healthcare:Health Information Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$15.30 (USD) 03/26/2021 Weighted Valuation$15.75 (USD) Overall RatingFairly valued to slightly Undervalued by 2.9% Valuation …
Allscripts Healthcare (MDRX:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report MGM Resorts Intl(MGM:NYS) Consumer Cyclical:Resorts & Casinos This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$37.68 (USD) 03/26/2021 Weighted Valuation$34.12 (USD) Overall RatingOvervalued by 9.4% Valuation Models …
MGM Resorts Intl (MGM:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Altria Group(MO:NYS) Consumer Defensive:Tobacco This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$52.50 (USD) 03/26/2021 Weighted Valuation$49.67 (USD) Overall RatingOvervalued by 5.4% Valuation Models Multiples: $46.94 (USD) Valuation …
Altria Group (MO:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Marathon Petroleum(MPC:NYS) Energy:Oil & Gas Refining & Marketing This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$55.02 (USD) 03/26/2021 Weighted Valuation$54.10 (USD) Overall RatingFairly valued to …
Marathon Petroleum (MPC:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report MPLX(MPLX:NYS) Energy:Oil & Gas Midstream This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$25.52 (USD) 03/26/2021 Weighted Valuation$28.33 (USD) Overall RatingUndervalued by 11.0% Valuation Models Comparables: $29.78 (USD) …
MPLX (MPLX:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Moderna(MRNA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$133.28 (USD) 03/26/2021 Weighted Valuation$180.43 (USD) Overall RatingUndervalued by 35.4% Valuation Models Comparables: $193.12 (USD) Valuation Methods This …
Moderna (MRNA:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Mersana Therapeutics(MRSN:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$16.63 (USD) 03/26/2021 Weighted Valuation$15.75 (USD) Overall RatingOvervalued by 5.3% Valuation Models Adjusted Book Value: $15.10 (USD) …
Mersana Therapeutics (MRSN:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Morgan Stanley(MS:NYS) Financial Services:Capital Markets This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$79.98 (USD) 03/26/2021 Weighted Valuation$76.63 (USD) Overall RatingFairly valued to slightly Overvalued by 4.2% Valuation …
Morgan Stanley (MS:NYS) Fundamental Valuation Report Read more »
Read More